Use of gene expression profiles of peripheral blood lymphocytes to distinguish BRCA1 mutation carriers in high risk breast cancer families

Cancer Informatics

Volumn 7, Issue , 2009, Pages 41-56

  Vuillaume, Marie Laure ^a   Uhrhammer, Nancy ^a   Vidal, Véronique ^b   Vidal, Valérie Sylvain ^b   Chabaud, Valérie ^b   Jesson, Beline ^b   Kwiatkowski, Fabrice ^a   Bignon, Yves Jean ^a  

^a CENTRE JEAN PERRIN   (France)

^b Biopôle Clermont Limagne   (France)

Author keywords

BRCA1; Gene expression profile; Hereditary breast cancer; Microarray; Molecular genetic diagnostics; Peripheral blood mononuclear cells

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA TRANSCRIPTION; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN GENOME; MALE; MICROARRAY ANALYSIS; NONSENSE MUTATION; ONCOGENE; PERIPHERAL LYMPHOCYTE; RNA HYBRIDIZATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 67649280379     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/cin.s931     Document Type: Article

References (27)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66-71.
2. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378(6559):789-792
3. Mullan PB, Quinn JE, Harkin DP. The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene. 2006;25(43):5854-5863
4. Starita LM, Parvin JD. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Current opinion in cell biology. 2003;15(3):345-350
5. Deng CX, Brodie SG. Roles of BRCA1 and its interacting proteins. Bioessays. 2000;22(8):728-737
6. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, et al. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci U S A. 2002;99(11):7560-7565
7. Bertucci F, Eisinger F, Tagett R, Sobol H, Birnbaum D. Re: Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst. 2002;94(19):1506-1507
8. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001;344(8):539-548
9. Hedenfalk I, Ringner M, Ben-Dor A, et al. Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci U S A. 2003;100(5):2532-2537
10. Hedenfalk IA. Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures. J Natl Cancer Inst. 2002;94(13):960-961
11. Hedenfalk IA, Ringner M, Trent JM, Borg A. Gene expression in inherited breast cancer. Adv Cancer Res. 2002;84:1-34.
12. Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst. 2002;94(13):990-1000.
13. van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530-536
14. Kote-Jarai Z, Williams RD, Cattini N, et al. Gene expression profiling after radiation-induced DNA damage is strongly predictive of BRCA1 mutation carrier status. Clin Cancer Res. 2004;10(3):958-963
15. Kote-Jarai Z, Matthews L, Osorio A, et al. Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage. Clin Cancer Res. 2006;12(13):3896-3901
16. Kote-Jarai Z, Salmon A, Mengitsu T, et al. Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers. Br J Cancer. 2006;94(2):308-310
17. Rothfuss A, Schutz P, Bochum S, et al. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res. 2000;60(2):390-394
18. Trenz K, Rothfuss A, Schutz P, Speit G. Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation. Mutat Res. 2002;500(1-2):89-96.
19. Gasser S, Raulet D. The DNA damage response, immunity and cancer. Semin Cancer Biol. 2006;16(5):344-347
20. Sharma P, Sahni NS, Tibshirani R, et al. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res. 2005;7(5):R634-44.
21. Chaussabel D, Allman W, Mejias A, et al. Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes. Ann N Y Acad Sci. 2005;1062:146-154
22. Radich JP, Mao M, Stepaniants S, et al. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics. 2004;83(6):980-988
23. Whitney AR, Diehn M, Popper SJ, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A. 2003;100(4):1896-1901
24. Andrews HN, Mullan PB, McWilliams S, et al. BRCA1 regulates the interferon gamma-mediated apoptotic response. J Biol Chem. 2002;277(29):26225- 26232
25. Takimoto R, MacLachlan TK, Dicker DT, Niitsu Y, Mori T, el-Deiry WS. BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation. Cancer Biol Ther. 2002;1(2):177-186
26. Castle J, Garrett-Engele P, Armour CD, et al. Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing. Genome Biol. 2003;4(10):R66.
27. Michiels S, Koscielny S, Boulet T, Hill C. [Gene expression profiling in cancer research]. Bull Cancer. 2007;94(11):976-980